Industry72°
Anthropic在IPO文件中披露进军药物研发计划
Why we picked it
Anthropic要在IPO文件里披露自建分子生物学实验室做药物研发了，还顺带列了风险清单，罕见地展示AI公司的生物布局。
Anthropic在IPO文件中披露了向药物研发领域的扩张计划。公司正在建设自己的分子生物学实验室，并投资可能最终产出药物候选分子的研究。文件同时列出了AI应用于药物研发的风险。
Original · Fierce Healthcare
Artificial intelligence giant Anthropic is pushing deeper into drug discovery, building its own molecular biology lab and investing in research that could eventually produce drug candidates, according to the company's blockbuster IPO filing.
